|
|
Post by lennymnkd on Jun 6, 2017 18:23:59 GMT -5
|
|
|
|
Post by sportsrancho on Jun 6, 2017 18:27:00 GMT -5
Talking about it on CNBC all day.
|
|
|
|
Post by lennymnkd on Jun 6, 2017 18:31:01 GMT -5
"With experience in video streaming, content creation, and the continued emergence and acceptance of telemedicine, Amazon may have eyes on an even larger prize - fully integrated digital healthcare," Maris explained. "So maybe Amazon will first conquer the pharmacy, and then conquer the doctor visit."
|
|
|
|
Post by kc on Jun 6, 2017 18:52:24 GMT -5
I am hoping that the Rite Aid buy out by Walgreens falls apart that Amazon buys Rite Aid .
Rite Aid is very cheap these days. If the Walgreens deal goes through it's at $6.50 or $6.75.
Today is closed at $3.47
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 6, 2017 19:00:36 GMT -5
I am hoping that the Rite Aid buy out by Walgreens falls apart that Amazon buys Rite Aid . Rite Aid is very cheap these days. If the Walgreens deal goes through it's at $6.50 or $6.75. Today is closed at $3.47 I dont think that deal is going through. |
|
|
|
Post by sayhey24 on Jun 6, 2017 19:17:50 GMT -5
This goes along with what Dachis was saying at the shareholders meeting. Hopefully Dachis has a team working on the Dexcom/Iwatch interface and the Abbott Libre interface to his tracking software. Mike mentioned in his 6/5 posted interview that Abbott has a "new product" about to hit the market. This is the Freestyle Libre which has a 1 minute sample rate and 8 hours of on sensor storage. It should be available without a prescription. They are saying they should be able to get dosing approval from the FDA.
Afrezza would be the perfect fit as Amazon's first "specialty" product which is what Mike called it in the interview. Combine afrezza with Dachis' system and telemedicine and its off to the races with Amazon. Amazon solves the cold chain storage issue with has not been discussed much but is a huge issue for local pharmacies if afrezza starts selling in volume.
Google, Apple and Amazon and not one BP. I like it. I wonder what Stefan Schwarz's next move will be? Amazon could very well crush Onduo. The good news is they all need afrezza for as Mike called it "real time control". With the new Libre making CGMs available to everyone at a low cost, doctors and BP can no longer hide the meal time sugar numbers.
|
|
|
|
Post by mnholdem on Jun 6, 2017 20:21:25 GMT -5
The real power behind this concept is that it helps put control - real control - into the hands of the patient. Another reason I find it so exciting is that this technology has the potential to truly expose The Good, The Bad & The Ugly of present-day diabetes treatments, which could result in a complete re-write of the Diabetes Standards of Care by the ADA and the medical community.
|
|
|
|
Post by sellhighdrinklow on Jun 6, 2017 21:42:34 GMT -5
This goes along with what Dachis was saying at the shareholders meeting. Hopefully Dachis has a team working on the Dexcom/Iwatch interface and the Abbott Libre interface to his tracking software. Mike mentioned in his 6/5 posted interview that Abbott has a "new product" about to hit the market. This is the Freestyle Libre which has a 1 minute sample rate and 8 hours of on sensor storage. It should be available without a prescription. They are saying they should be able to get dosing approval from the FDA. Afrezza would be the perfect fit as Amazon's first "specialty" product which is what Mike called it in the interview. Combine afrezza with Dachis' system and telemedicine and its off to the races with Amazon. Amazon solves the cold chain storage issue with has not been discussed much but is a huge issue for local pharmacies if afrezza starts selling in volume. Google, Apple and Amazon and not one BP. I like it. I wonder what Stefan Schwarz's next move will be? Amazon could very well crush Onduo. The good news is they all need afrezza for as Mike called it "real time control". With the new Libre making CGMs available to everyone at a low cost, doctors and BP can no longer hide the meal time sugar numbers. Maybe Amazon has been the one shorting MNKD stock all along. |
|
